Prepare, dose, administer, and get results.
Diagnosis made simpler. Decisions made clear.
Macrilen™ is the first and only FDA-approved Adult Growth Hormone Deficiency (AGHD) oral diagnostic test available for in-office use.1
Diagnosis made simpler. Decisions made clear.
Macrilen™ is the first and only FDA-approved Adult Growth Hormone Deficiency (AGHD) oral diagnostic test available for in-office use.1

Model is for illustrative purposes only.
In-office administration

Co-pay assistance

We can help with the cost of Macrilen™. Your eligible patients may pay as little as $75.a,b
aWith an annual co-pay assistance of up to $4425.
bThis is a one-time use offer. Enrollment in the co-pay program is subject to eligibility criteria and terms and conditions, and the enrollment timeframe is based on calendar year. Coverage is limited to co-pay or co-insurance for Macrilen™ product only and does not include deductible amounts or other office visits, procedures, or administration costs. Novo Nordisk has the right to charge, alter, or revoke eligibility criteria and terms and conditions at any time.